wintix msds - Ancare

WINTIX ®Pour-On Tick Development InhibitorVersion: 2Issue Date: 10 November 2011Page 3 of 5SECTION 8Exposure Limits:Exposure Potential:Respirator:General advice:EXPOSURE CONTROLS/PERSONAL PROTECTIONNo exposure standards have been established for the components of this product.Swallowing is unlikely under normal conditions of usage. Exposure by inhalation isunlikely. Skin uptake is the main route of exposure.No respirator is required under normal conditions of use.Avoid contact with eyes and skin. When opening the container and using theproduct, wear cotton overalls buttoned to the neck and wrist, a washable hat, elbowlength PVC gloves and a face shield. If clothing becomes contaminated with productremove clothing immediately. If product on skin, immediately wash area with soapand water. If product in eyes, wash it out immediately with water. After use andbefore eating, drinking and smoking, wash hands, arms and face thoroughly withsoap and water. After each day’s use, wash gloves, face shield and contaminatedclothing.SECTION 9Physical State: LiquidColour:Clear slightly yellowOdour:Slightly like ammoniaCorrosiveness: Non-corrosiveViscosity (25°C): 15 – 30 mPasSpecific gravity (20°C): 1.04Flash point:92°C (closed cup)Flammability: Non-flammableCombustibility: CombustibleSECTION 10PHYSICAL AND CHEMICAL PROPERTIESSTABILITY & REACTIVITYChemical Stability: Product is stable. No hazardous reactionsIncompatible Materials: NoneSECTION 11Acute Toxicity :Oral:Dermal:Inhalation:Local Effects:IrritationEye:Skin:Respiratory System:SensitisationSkin:Poisoning Symptoms:TOXICOLOGICAL INFORMATIONLow toxicity.Tests on rats indicate a low toxicity following single doses of undiluted product.LD50 >2000 mg/kg.Low toxicity.Tests on rats indicate low toxicity due to contact with undiluted product.LD50 >4000 mg/kg.Toxicity by inhalation is not determinedHighly irritating (Based on studies with pyrrolidone components)Highly irritating (Based on studies with pyrrolidone components and WINTIX)Irritating. (Based on studies with the pyrrolidone)(Based on results on guinea-pigs)Neither Fluazuron technical nor N-(N-octyl)-2- pyrrolidone induced sensitisation onguinea pig and human skin, respectively, but N-(Ndodecyl)-2- pyrrolidone showeddelayed contact hypersensitivity in guinea pigs.Ingestion is likely to cause smarting and burning sensations, inflammation, burns andpainful blisters of the mouth, throat and digestive tract. Exposure by inhalation isunlikely but the effects would be irritation of mucous membranes, nose, eyes andthroat, coughing and difficulty in breathing. Based on tests with the components, theproduct is likely to cause a smarting and burning sensation on skin or eye contact.